Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ullman

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|September 25, 2013
The application of next generation sequencing to the understanding of antibody repertoiresPascale Mathonet, Christopher G Ullman
Frontiers in Chemistry|January 7, 2016
Recent Advances Toward the Discovery of Drug-Like Peptides De novoMichael Goldflam, Christopher G Ullman
Journal of Abnormal Child Psychology|January 1, 1975
A comparison of objective measures of activity and distractibility in hyperactive and nonhyperactive childrenR A Barkley, D G Ullman
Journal of Abnormal Child Psychology|June 1, 1983
The effects of stimulant drugs on curiosity behaviors of hyperactive boysN L Fiedler, D G Ullman
Orthopedics|May 15, 2014
Peroneal intraneural ganglionM Roffman, D G Mendes, G Ullman
Future Medicinal Chemistry|December 23, 2014
Library construction, selection and modification strategies to generate therapeutic peptide-based modulators of protein-protein interactionsDaniel Baxter, Christopher G Ullman, Jody M Mason
Biochemistry|October 7, 1998
Possible arrangement of the five domains in human complement factor I as determined by a combination of X-ray and neutron scattering and homology modelingD Chamberlain, C G Ullman, S J Perkins
Briefings in Functional Genomics|June 2, 2011
In vitro methods for peptide display and their applicationsChristopher G Ullman, Laura Frigotto, R Neil Cooley
The American Journal of Orthopsychiatry|July 1, 1978
The behavioral symptoms of hyperkinetic children who successfully responded to stimulant drug treatmentDouglas G Ullman, Russell A Barkley, H Wesley Brown
ACS Chemical Biology|September 8, 2017
Exploiting Overlapping Advantages of In Vitro and In Cellulo Selection Systems to Isolate a Novel High-Affinity cJun AntagonistDaniel Baxter, Christopher G Ullman, Laura Frigotto, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|September 25, 2013
The application of next generation sequencing to the understanding of antibody repertoiresPascale Mathonet, Christopher G Ullman
Frontiers in Chemistry|January 7, 2016
Recent Advances Toward the Discovery of Drug-Like Peptides De novoMichael Goldflam, Christopher G Ullman
Journal of Abnormal Child Psychology|January 1, 1975
A comparison of objective measures of activity and distractibility in hyperactive and nonhyperactive childrenR A Barkley, D G Ullman
Journal of Abnormal Child Psychology|June 1, 1983
The effects of stimulant drugs on curiosity behaviors of hyperactive boysN L Fiedler, D G Ullman
Orthopedics|May 15, 2014
Peroneal intraneural ganglionM Roffman, D G Mendes, G Ullman
Future Medicinal Chemistry|December 23, 2014
Library construction, selection and modification strategies to generate therapeutic peptide-based modulators of protein-protein interactionsDaniel Baxter, Christopher G Ullman, Jody M Mason
Biochemistry|October 7, 1998
Possible arrangement of the five domains in human complement factor I as determined by a combination of X-ray and neutron scattering and homology modelingD Chamberlain, C G Ullman, S J Perkins
Briefings in Functional Genomics|June 2, 2011
In vitro methods for peptide display and their applicationsChristopher G Ullman, Laura Frigotto, R Neil Cooley
The American Journal of Orthopsychiatry|July 1, 1978
The behavioral symptoms of hyperkinetic children who successfully responded to stimulant drug treatmentDouglas G Ullman, Russell A Barkley, H Wesley Brown
ACS Chemical Biology|September 8, 2017
Exploiting Overlapping Advantages of In Vitro and In Cellulo Selection Systems to Isolate a Novel High-Affinity cJun AntagonistDaniel Baxter, Christopher G Ullman, Laura Frigotto, et al.
Pageof 3